「Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.」の関連論文
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
-
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
-
Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
-
Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
-
Finding potential synergistic drugs to reduce chemo-resistance for the treatment of highly malignant tumors in female
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Survival Analyses Based on Tumor Microenvironment Profile in Endometrial Carcinoma
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
分子標的薬時代における転移性腎癌の腫瘍縮小率が予後に与える影響
-
Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
-
Neutrophil–lymphocyte Ratio and Histological Response Correlate With Prognosis of Gastric Cancer Undergoing Neoadjuvant Chemotherapy
-
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
-
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study
-
MDM4 as a prognostic factor for patients with gastric cancer with low expression of p53:immunohistochemical study of p53, MDM2, and MDM4
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
-
Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer
-
Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
-
腎癌脳転移に対する局所療法の有効性に関する検討
-
Comparison of cytoreductive surgery and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer: a retrospective study
-
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy
-
Evaluating the effect of lenvatinib on sorafenib-resistant hepatocellular carcinoma cells
-
Clinical and Basic Research for Ovarian Cancer
-
Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
-
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
-
The baseline recurrence risk of patients with intermediate-risk cervical cancer.
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
-
Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer
-
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial